Neurogenic Mechanisms in Burning Mouth Syndrome
BMS17
1 other identifier
interventional
22
1 country
1
Brief Summary
Burning mouth syndrome (BMS) is characterized by a bilateral burning sensation in the anterior tongue, hard palate and lips in the absence of any clinical or laboratory findings. The term syndrome implicates the simultaneous presence of oral dryness (xerostomia) and altered taste (dysgeusia) in addition to the burning sensation in the oral mucosa. BMS is most often seen in women and is more frequent during menopause. The etiology and pathogenesis are still unclear but recent studies suggest that BMS is a neuropathic pain condition. The objectives of the study are:
- To clarify potential neurogenic mechanisms behind BMS using immunohistochemistry (IH) to characterize the localization and distribution of peripheral nerve fibres, neuropeptides like substance P, calcitonin gene-related peptide, nerve growth factor, nerve growth factor receptor, PGP 9.5 neuronal marker and TRPV1 as well as inflammatory/structural changes.
- To perform a randomized double blind cross-over intervention study to examine the efficacy and safety of topical application of capsaicin oral gel (on the tongue) to relieve the burning sensation in patients with BMS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 2, 2009
CompletedFirst Posted
Study publicly available on registry
April 3, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedMarch 14, 2017
March 1, 2017
1.2 years
April 2, 2009
March 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome: To evaluate the efficacy and safety of topical application of capsaicin oral gel (using to different concentrations) to relieve the burning sensation in patients with BMS and alleviate BMS related symptoms.
6 months
Secondary Outcomes (1)
To characterize the localization and distribution of peripheral nerve fibres, neuropeptides like substance P, calcitonin gene-related peptide, NGF, NGF-R, PGP 9.5 neuronal marker and TRPV1 as well as inflammatory/structural changes.
6 months
Study Arms (2)
Capsaicin oral gel 0.01%
ACTIVE COMPARATORCapsaicin oral gel 0.025%
ACTIVE COMPARATORInterventions
Application 3 times daily for 14 days on the tongue, followed by 14 days wash-out
Application 3 times daily for 14 days on the tongue, followed by 14 days wash-out
Eligibility Criteria
You may qualify if:
- non-smoking female patients with burning mouth syndrome (n=26)
- healthy aged-matched control group (n=10)
You may not qualify if:
- women who do not use safe anticonception
- patients with know allergy/hypersensitivity to capsicum and other capsaicinoid-containing products
- Active infection which requires antibiotic treatment
- patients who are able to give informed consent due to physical or mental disabilities
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Odontology, Section of Oral Medicine, Clinical Oral Physiology, Oral Pathology & Anatomy
Copenhagen, 2200, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, PhD, DDS
Study Record Dates
First Submitted
April 2, 2009
First Posted
April 3, 2009
Study Start
January 1, 2009
Primary Completion
April 1, 2010
Study Completion
June 1, 2010
Last Updated
March 14, 2017
Record last verified: 2017-03